DE69623038D1 - Verfahren zur herstellung von n-acetyl(l)-4-cyanophenylalanin ac-(l)-phe(4-cn)-phe(4-cn)-oh und n-acetyl-(l)-p-amidinophenylalanin-cyclohexylglycin-beta-(3-n-methylpyridinium)-alanin ac-(l)-paph-chg-palme(3)-nh2 - Google Patents

Verfahren zur herstellung von n-acetyl(l)-4-cyanophenylalanin ac-(l)-phe(4-cn)-phe(4-cn)-oh und n-acetyl-(l)-p-amidinophenylalanin-cyclohexylglycin-beta-(3-n-methylpyridinium)-alanin ac-(l)-paph-chg-palme(3)-nh2

Info

Publication number
DE69623038D1
DE69623038D1 DE69623038T DE69623038T DE69623038D1 DE 69623038 D1 DE69623038 D1 DE 69623038D1 DE 69623038 T DE69623038 T DE 69623038T DE 69623038 T DE69623038 T DE 69623038T DE 69623038 D1 DE69623038 D1 DE 69623038D1
Authority
DE
Germany
Prior art keywords
phe
acetyl
cyclohexylglycin
paph
amidinophenylalanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69623038T
Other languages
English (en)
Other versions
DE69623038T2 (de
Inventor
R King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69623038D1 publication Critical patent/DE69623038D1/de
Publication of DE69623038T2 publication Critical patent/DE69623038T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/02Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
DE69623038T 1995-12-20 1996-11-25 Verfahren zur herstellung von n-acetyl(l)-4-cyanophenylalanin ac-(l)-phe(4-cn)-phe(4-cn)-oh und n-acetyl-(l)-p-amidinophenylalanin-cyclohexylglycin-beta-(3-n-methylpyridinium)-alanin ac-(l)-paph-chg-palme(3)-nh2 Expired - Lifetime DE69623038T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57556995A 1995-12-20 1995-12-20
PCT/US1996/019005 WO1997022712A1 (en) 1995-12-20 1996-11-25 NOVEL PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-β-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH¿2?

Publications (2)

Publication Number Publication Date
DE69623038D1 true DE69623038D1 (de) 2002-09-19
DE69623038T2 DE69623038T2 (de) 2002-12-12

Family

ID=24300839

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69623038T Expired - Lifetime DE69623038T2 (de) 1995-12-20 1996-11-25 Verfahren zur herstellung von n-acetyl(l)-4-cyanophenylalanin ac-(l)-phe(4-cn)-phe(4-cn)-oh und n-acetyl-(l)-p-amidinophenylalanin-cyclohexylglycin-beta-(3-n-methylpyridinium)-alanin ac-(l)-paph-chg-palme(3)-nh2

Country Status (27)

Country Link
EP (1) EP0868526B1 (de)
JP (1) JP4044614B2 (de)
KR (1) KR100438879B1 (de)
CN (1) CN1087349C (de)
AR (1) AR005119A1 (de)
AT (1) ATE222293T1 (de)
AU (1) AU717995B2 (de)
BR (1) BR9612059A (de)
CA (1) CA2241210C (de)
CZ (1) CZ295362B6 (de)
DE (1) DE69623038T2 (de)
DK (1) DK0868526T3 (de)
EE (1) EE03698B1 (de)
ES (1) ES2179957T3 (de)
HK (1) HK1017384A1 (de)
IL (1) IL125003A (de)
MX (1) MX9804997A (de)
NO (1) NO319678B1 (de)
NZ (1) NZ324159A (de)
PL (1) PL185541B1 (de)
PT (1) PT868526E (de)
RU (1) RU2170764C2 (de)
SK (1) SK281432B6 (de)
TR (1) TR199801107T2 (de)
UA (1) UA48993C2 (de)
WO (1) WO1997022712A1 (de)
ZA (1) ZA9610600B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9916732A (pt) * 1999-01-02 2001-09-25 Aventis Pharma Gmbh Derivados de ácido malÈnico, processo para a sua preparação, seu uso e composições farmacêuticas contendo-os (inibição da atividade do fator xa)
EP1016663A1 (de) * 1999-01-02 2000-07-05 Aventis Pharma Deutschland GmbH Neue Malonsäure Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung und pharmazeutische Zusammensetzungen sie enthaltend (Inhibierung der Faktor Xa Aktivität)
RU2250212C2 (ru) * 2000-01-28 2005-04-20 Авентис Фарма Дойчланд Гмбх Способ получения ацетиламидиниофенилаланилциклогексилглицилпиридиниоаланинамидов
EP1127884A1 (de) * 2000-02-26 2001-08-29 Aventis Pharma Deutschland GmbH Neue Malonsäure Derivaie, Verfahren zu ihrer Herstellung, ihre Verwendung als Inhibitor der Faktor XA Aktivtät und pharmazeutische Zusammensetzungen diese enthaltend
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia
GB0306267D0 (en) * 2003-03-19 2003-04-23 Ineos Fluor Ltd Process
JP2008260755A (ja) * 2007-03-20 2008-10-30 Sumitomo Chemical Co Ltd L−ビフェニルアラニン化合物の塩の回収方法、およびそれを用いたビフェニルアラニンエステル化合物の回収方法
CN106946724B (zh) * 2017-04-07 2019-03-22 苏州汉德创宏生化科技有限公司 单胺基抑制剂类中间体2-乙酰氨基-2-苄基丙二酸单乙酯的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981799A (en) * 1987-08-21 1991-01-01 Takeda Chemical Industries, Ltd. Acylamino acid racemase, production and use thereof
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE69213546T2 (de) * 1991-05-13 1997-02-27 Fujisawa Pharmaceutical Co Neue Peptid-Verbindungen und Verfahren zur Herstellung davon
ATE262536T1 (de) * 1994-04-26 2004-04-15 Aventis Pharma Inc Faktor xa inhibitoren

Also Published As

Publication number Publication date
RU2170764C2 (ru) 2001-07-20
ZA9610600B (en) 1997-06-20
CZ195698A3 (cs) 1999-01-13
DE69623038T2 (de) 2002-12-12
ES2179957T3 (es) 2003-02-01
EP0868526B1 (de) 2002-08-14
CN1087349C (zh) 2002-07-10
ATE222293T1 (de) 2002-08-15
IL125003A (en) 2001-12-23
HK1017384A1 (en) 1999-11-19
DK0868526T3 (da) 2002-12-02
NO982868L (no) 1998-08-19
NO982868D0 (no) 1998-06-19
UA48993C2 (uk) 2002-09-16
TR199801107T2 (xx) 1998-10-21
CA2241210C (en) 2002-05-14
NO319678B1 (no) 2005-09-05
NZ324159A (en) 1999-07-29
JP2000501618A (ja) 2000-02-15
PL185541B1 (pl) 2003-05-30
WO1997022712A1 (en) 1997-06-26
JP4044614B2 (ja) 2008-02-06
PL327314A1 (en) 1998-12-07
EE03698B1 (et) 2002-04-15
EP0868526A1 (de) 1998-10-07
BR9612059A (pt) 1999-02-23
IL125003A0 (en) 1999-01-26
AU1125197A (en) 1997-07-14
CA2241210A1 (en) 1997-06-26
CN1205742A (zh) 1999-01-20
CZ295362B6 (cs) 2005-07-13
KR20000064486A (ko) 2000-11-06
KR100438879B1 (ko) 2004-07-16
SK281432B6 (sk) 2001-03-12
SK85598A3 (en) 1998-12-02
MX9804997A (es) 1998-09-30
AU717995B2 (en) 2000-04-06
PT868526E (pt) 2002-12-31
EE9800188A (et) 1998-12-15
AR005119A1 (es) 1999-04-14

Similar Documents

Publication Publication Date Title
DE69625875D1 (de) Verfahren und Vorrichtung zur Sprachkodierung und -dekodierung
DE69430872T2 (de) System und verfahren zur sprachkompression
DE69532029D1 (de) Verfahren zur Kodierung und Vorrichtung dafür
DE69826478D1 (de) Verfahren und vorrichtung zur herstellung von dünnen funktionsfilmen
ATE204291T1 (de) Verfahren zur herstellung von peptiden und n- carbamoyl-geschützten peptiden
HUP9801990A3 (en) Peptide and method of obtaining it
DE69618705T2 (de) Verfahren und Vorrichtung zur Herstellung von Bürstenkörpern
DE59606918D1 (de) Verfahren zur auswahl und zum abruf von multimedia-diensten
DE69207178D1 (de) Verbindungen und verfahren zur aminosäurensequenzierung
DE59606881D1 (de) Verfahren und vorrichtung zur herstellung von borstenwaren und danach hergestellte borstenware
DE69506449T2 (de) Verfahren und vorrichtung zur zwischenbildkodierung
ATE178586T1 (de) Verfahren zur herstellung von n-aryl- und n- hetarylhydroxylaminen
DE69621168T2 (de) Verfahren und System zur Software-Codierung und -Decodierung
DE69705626D1 (de) Verbessertes verfahren zur herstellung von polyamid- und ionischen copolymer-mischungen
DE69623038T2 (de) Verfahren zur herstellung von n-acetyl(l)-4-cyanophenylalanin ac-(l)-phe(4-cn)-phe(4-cn)-oh und n-acetyl-(l)-p-amidinophenylalanin-cyclohexylglycin-beta-(3-n-methylpyridinium)-alanin ac-(l)-paph-chg-palme(3)-nh2
DE69608301T2 (de) Verfahren zur co-produktion von amoniak und methanol
DE69522561D1 (de) Verfahren zur herstellung von benzophentionen und benzophenonen
DE59711992D1 (de) Verfahren und mittel zur dauerhaften haarverformung
DE59607872D1 (de) Verfahren zur Herstellung von beidseitig amidierten Triphendioxazinfarbstoffen und neue Triphendioxazinfarbstoffe
ATE191779T1 (de) Einrichtung und verfahren zur herstellung von beschichtungen
DE69617643D1 (de) Verfahren zur herstellung von difluormethan und difluorchlormethan
DE69628294D1 (de) Verfahren zur herstellung von tertiären aminocarbonaten und aminoethern
DE69505632D1 (de) Verfahren zur herstellung von cycloalkanolen und cycloalkanonen
SI0868526T1 (en) PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-BETA-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH2
DE59803300D1 (de) Verfahren zur herstellung von isomelezitose und isomelezitose-haltigen süssungsmitteln

Legal Events

Date Code Title Description
8364 No opposition during term of opposition